BridgeMD
New treatment option for Hypertensive Heart Disease Without (Congestive) Heart Failure
Official title The Influence of Beetroot Powder at a Dose of 20 g on Blood Pressure, Microcirculation, and Biochemical Markers in Men With Arterial Hypertension.SVEKLA2025.
ClinicalTrials.gov ID: NCT07270718
What this study is testing
- What it's testing
- Objective: to evaluate the effectiveness of using a food product, dry finely dispersed beetroot powder in a dose of 20 g, containing 800 mg of nitrate (NO3-), in relation to the regulation of blood pressure in men with hypertension who reached the target blood pressure level while taking optimal antihypertensive therapy. Characteristics of the study: randomized, open, and cross-sectional.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60, men only. Healthy volunteers may be eligible.
You may be able to join if
- A history of hypertension with achievement of the target blood pressure level according to the SMAD while taking regular AGT;
- signing informed consent to participate in the study.
You likely can't join if
- coronary heart disease, including angina pectoris and myocardial infarction; cerebrovascular disease, including acute cerebrovascular accident and...
- BMI ≥30 kg/m2;
- symptoms of heart failure;
- acute infectious diseases at the time of inclusion in the study and within 1 month prior to inclusion in the study;
- Exacerbation of chronic non-communicable diseases;
- alcoholism, taking narcotic drugs;
See the full eligibility criteria
- A history of hypertension with achievement of the target blood pressure level according to the SMAD while taking regular AGT;
- signing informed consent to participate in the study.
- coronary heart disease, including angina pectoris and myocardial infarction; cerebrovascular disease, including acute cerebrovascular accident and transient ischemic attack; obliterating atherosclerosis of peripheral...
- BMI ≥30 kg/m2;
- symptoms of heart failure;
- acute infectious diseases at the time of inclusion in the study and within 1 month prior to inclusion in the study;
- Exacerbation of chronic non-communicable diseases;
- alcoholism, taking narcotic drugs;
- allergic and undesirable reactions to foods containing beetroot and egg white in the anamnesis;
- refusal to continue participating in the study
The study team makes the final eligibility decision.
Where it's taking place
- Moscow, Russia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years to 60 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Moscow, Russia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.